Re: Maria S. Lindgren, Eric Hansen, Nessn Azawi, Anna M. Nielsen, Lars Dyrskjøt, Jørgen B. Jensen. DaBlaCa-13 Study: Oncological Outcome of Short-term, Intensive Chemoresection with Mitomycin in Nonmuscle Invasive Bladder Cancer: Primary Outcome of a Randomized Controlled Trial. J Clin Oncol. In press. https://doi.org/10.1200/JCO.22.00470
Eur Urol. 2023 Apr;83(4):e105-e106.
doi: 10.1016/j.eururo.2022.12.036.
Epub 2023 Jan 28.
1 Department of Urology UROSUD, La Croix Du Sud Hospital, Quint Fonsegrives, France; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
2 Department of Urology, IRCCS San Raffaele Hospital, Milan, Italy.
3 Department of Urology, Pitié-Salpêtrière Hospital, APHP, Sorbonne University, GRC 5, Predictive Onco-Urology, Paris, France. Electronic address: [email protected].